Molecular docking study and molecular dynamics simulation of spice metabolites against main protease enzymes and NSP3 macrodomain SARS CoV-2

Authors

  • Purwaniati Purwaniati Pharmaceutical Analysis and Medicinal Chemistry, Pharmacy Faculty, Universitas Bhakti Kencana
  • Asep Roni Pharmaceutical Biology, Pharmacy Faculty, Universitas Bhakti Kencana

DOI:

https://doi.org/10.12928/pharmaciana.v12i1.21501

Keywords:

COVID-19, main protease, molecular docking, NSP3 macrodomain, SARS CoV-2

Abstract

COVID-19 is still a global pandemic. The transmission is very fast and wide. Its prevalence continues to increase. There is no specific antiviral drug for SARS CoV 2 yet. This study aims to find lead compounds from compounds derived from spices that can work as multitarget SARS CoV-2 antivirals. The target of drug action chosen in this study is the main protease enzyme and non-structural protein 3 (NSP3) macrodomain. Antiviral compounds that work on both targets are expected to be more potent. This antivirus will work to inhibit virus replication through main protease inhibition and increase innate immunity through NSP3 macrodomain inhibition. Molecular docking and molecular dynamics simulation were chosen as the methods in this study. Based on the results of molecular docking, it was found that the compound of dauricine, tomentin A, daurisoline, xhantoangelol, rutin and myricetin gave good affinity to both targets. These compounds provide an inhibition constant below 10000 nM or 10 micromolar. Meanwhile, in the molecular dynamics simulation test, it was found that dauricine, rutin, myricetin, and xhantoangelol have good interaction stability with both targets. So from this study, it can be concluded that dauricine, rutin, myricetin and xhantoangelol are potential compounds as lead compounds for SARS CoV-2 antivirals that act on the main protease and the NSP3 macrodomain.

References

Anand, K., Ziebuhr, J., Wadhwani, P., Mesters, J. R., & Hilgenfeld, R. (2003). Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs. 300(June), 1763-1768. https://doi.org/10.1126/science.1085658

Banerjee, R., Perera, L., & Tillekeratne, L. M. V. (2021). Potential SARS-CoV-2 main protease inhibitors. Drug Discovery Today, 26(3), 804-816. https://doi.org/10.1016/j.drudis.2020.12.005

Belouzard S. et all. (2012). Mechanisms of coronavirus cell entry mediated by the viral spike protein. 1011-1033. https://doi.org/10.3390/v4061011

Belouzard, S., Millet, J. K., Licitra, B. N., & Whittaker, G. R. (2012). Mechanisms of coronavirus cell entry mediated by the viral spike protein. In Viruses. https://doi.org/10.3390/v4061011

Chen, D., Oezguen, N., Urvil, P., Ferguson, C., Dann, S. M., & Savidge, T. C. (2016). Regulation of protein-ligand binding affinity by hydrogen bond pairing. Science Advances, 2(3). https://doi.org/10.1126/sciadv.1501240

Cui, W., Yang, K., & Yang, H. (2020). Recent Progress in the Drug Development Targeting SARS-CoV-2 Main Protease as Treatment for COVID-19. Frontiers in Molecular Biosciences, 7(December), 1-10. https://doi.org/10.3389/fmolb.2020.616341

Dermawan, D., Sumirtanurdin, R., & Dewantisari, D. (2019). Molecular dynamics simulation of estrogen receptor alpha against andrografolid as anti breast cancer simulasi dinamika molekular reseptor estrogen alfa dengan andrografolid sebagai anti kanker payudara. 6(2). https://doi.org/10.24198/ijpst.v6i2.18168

Ibrahim, M. A. A., Abdelrahman, A. H. M., Hussien, T. A., Badr, E. A. A., Mohamed, T. A., El-Seedi, H. R., Pare, P. W., Efferth, T., & Hegazy, M. E. F. (2020). In silico drug discovery of major metabolites from spices as SARS-CoV-2 main protease inhibitors. Computers in Biology and Medicine, 126(October), 104046. https://doi.org/10.1016/j.compbiomed.2020.104046

Ivashkiv, L. B., & Donlin, L. T. (2014). Regulation of type i interferon responses. Nature Reviews Immunology, 14(1), 36-49. https://doi.org/10.1038/nri3581

Jung, L. S., Gund, T. M., & Narayan, M. (2020). Comparison of Binding Site of Remdesivir and Its Metabolites with NSP12-NSP7-NSP8, and NSP3 of SARS CoV-2 Virus and Alternative Potential Drugs for COVID-19 Treatment. Protein Journal, 39(6), 619-630. https://doi.org/10.1007/s10930-020-09942-9

Kairys, V., Baranauskiene, L., Kazlauskiene, M., Matulis, D., & Kazlauskas, E. (2019). Binding affinity in drug design: experimental and computational techniques. Expert Opinion on Drug Discovery, 14(8), 755-768. https://doi.org/10.1080/17460441.2019.1623202

Mielech, A. M., Chen, Y., Mesecar, A. D., & Baker, S. C. (2014). Nidovirus papain-like proteases: Multifunctional enzymes with protease, deubiquitinating and deISGylating activities. January. https://doi.org/10.1016/j.virusres.2014.01.025

Morris G.M., & Dallakyan S. (2013). AutoDock AutoDock. 02-27

Morse, J. S., Lalonde, T., Xu, S., & Liu, W. R. (2020). Learning from the Past: Possible Urgent Prevention and Treatment Options for Severe Acute Respiratory Infections Caused by 2019-nCoV. ChemBioChem, 21(5), 730-738. https://doi.org/10.1002/cbic.202000047

Ni, X., Schröder,, M., Olieric, V., Sharpe, M. E., Hernandez-Olmos, V., Proschak, E., Merk, D., Knapp, S., & Chaikuad, A. (2021). Structural Insights into Plasticity and Discovery of Remdesivir Metabolite GS-441524 Binding in SARS-CoV-2 Macrodomain. ACS Medicinal Chemistry Letters, 12(4), 603-609. https://doi.org/10.1021/acsmedchemlett.0c00684

Oerlemans, R., Ruiz-moreno, A. J., Cong, Y., Kumar, N. D., Velasco-velazquez, D. M. A., Neochoritis, C. G., Smith, J., Reggiori, F., Groves, R., & Dömling, A. (2021). Repurposing the HCV NS3-4A protease drug boceprevir as COVID-19 therapeutics. 370-379. https://doi.org/10.1039/d0md00367k

Prasansuklab, A., Theerasri, A., Rangsinth, P., Sillapachaiyaporn, C., Chuchawankul, S., & Tencomnao, T. (2021). Anti-COVID-19 drug candidates: A review on potential biological activities of natural products in the management of new coronavirus infection. Journal of Traditional and Complementary Medicine, 11(2), 144-157. https://doi.org/10.1016/j.jtcme.2020.12.001

Purwaniati. (2020). Target Kerja Obat Antivirus COVID-19; Review. Farmagazine, VII(2), 30-42. https://ejournals.stfm.ac.id/index.php/JurnalFarmagazine/article/view/172/pdf. https://doi.org/10.47653/farm.v7i2.172

Russo, L. C., Tomasin, R., Matos, I. A., Manucci, A. C., Sowa, S. T., Dale, K., Caldecott, K. W., Lehti, L., Schechtman, D., Meotti, F. C., Bruni-cardoso, A., & Hoch, N. C. (2021). The SARS-CoV-2 Nsp3 macrodomain reverses PARP9/DTX3L-dependent ADP-ribosylation induced by interferon signalling. Journal of Biological Chemistry, 101041. https://doi.org/10.1016/j.jbc.2021.101041

Schoggins, J. W. (2019). Interferon-Stimulated Genes: What Do They All Do? Annual Review of Virology, 6, 567-584. https://doi.org/10.1146/annurev-virology-092818-015756

Sharif, F., Yunus, A. M., Saedudin, R. D. R., Azzar, A., Hamid, A., & Kasim, S. (2018). Molecular Docking and Dynamics ( MD ) Simulation of 6- gingerol and 6-shogaol Against Human Estrogen Receptor Alpha ( ER É‘ ). 10, 119-127. https://doi.org/10.30880/ijie.2018.10.06.016

Trott, O., & Olson, A. J. (2009). AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. Journal of Computational Chemistry, 31(2), NA-NA. https://doi.org/10.1002/jcc.21334

Wu, C., Liu, Y., Yang, Y., Zhang, P., Zhong, W., Wang, Y., Wang, Q., Xu, Y., Li, M., Li, X., Zheng, M., Chen, L., & Li, H. (2020). Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods. Acta Pharmaceutica Sinica B. https://doi.org/10.1016/j.apsb.2020.02.008

Yang, X. Q., Liu, J. Y., Li, X. C., Chen, M. H., & Zhang, Y. L. (2014). Key amino acid associated with acephate detoxification by Cydia pomonella carboxylesterase based on molecular dynamics with alanine scanning and site-directed mutagenesis. Journal of Chemical Information and Modeling, 54(5), 1356-1370. https://doi.org/10.1021/ci500159q

Yunta, M. J. R. (2016). Docking and Ligand Binding Affinity: Uses and Pitfalls. 4(3), 74-114. https://doi.org/10.12691/ajmo-4-3-2

Zhou, P., Yang, X., Wang, X., Hu, B., Zhang, L., Zhang, W., Guo, H., Jiang, R., Liu, M., Chen, Y., Shen, X., Wang, X., Zhan, F., Wang, Y., Xiao, G., & Shi, Z. (2020). A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature, 579(March). https://doi.org/10.1038/s41586-020-2012-7

Downloads

Published

2022-03-10

Issue

Vol. 12 No. 1 (2022): Pharmaciana

Section

Analytical Pharmacy and Medicinal Chemistry

License

Authors who publish with Pharmaciana agree to the following terms:

  1. Authors retain copyright and grant the journal the right of first publication with the work simultaneously licensed under a Creative Commons Attribution License (CC BY-SA 4.0) that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal. 
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.